A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer

NCT06457503 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Nasopharyngeal Cancer Recurrent

Interventions

DRUG: Toripalimab
DRUG: Cisplatin
DRUG: Gemcitabine
DRUG: Carboplatin

Sponsor

Coherus Oncology, Inc.